<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>In Light of Vioxx, Bextra Getting A Closer Look</title><link>http://articles.mercola.com/sites/articles/archive/2004/11/06/bextra-vioxx.aspx</link><description>Pulling Vioxx off the market made an impact on the &amp;quot;drug world.&amp;quot; The drug company Pfizer made the decision to conduct long-term cardiovascular tests on its pain drug Bextra, in order to discover if any hidden side effects existed. Researchers</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>